TOR in the immune system.

[1]  R. Zamoyska,et al.  The influence of mTOR on T helper cell differentiation and dendritic cell function , 2011, European journal of immunology.

[2]  S. Benhamron,et al.  Direct activation of mTOR in B lymphocytes confers impairment in B‐cell maturation andloss of marginal zone B cells , 2011, European journal of immunology.

[3]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[4]  Francis S Collins,et al.  Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells , 2011, Science Translational Medicine.

[5]  D. Green,et al.  Tuberous sclerosis complex 1 (Tsc1) enforces quiescence of naive T cells to promote immune homeostasis and function , 2011, Nature immunology.

[6]  M. Jenkins,et al.  Origins of CD4+ effector and central memory T cells , 2011, Nature Immunology.

[7]  Qingsheng Li,et al.  A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. , 2011, Immunity.

[8]  L. Partridge,et al.  A longer and healthier life with TOR down-regulation: genetics and drugs. , 2011, Biochemical Society transactions.

[9]  Pankaj Kapahi,et al.  TOR signaling never gets old: Aging, longevity and TORC1 activity , 2011, Ageing Research Reviews.

[10]  B. Kennedy,et al.  Hot topics in aging research: protein translation and TOR signaling, 2010 , 2011, Aging cell.

[11]  S. Crotty,et al.  Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.

[12]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[13]  W. Oppliger,et al.  Activation of mTORC2 by Association with the Ribosome , 2011, Cell.

[14]  A. Kirk,et al.  Sirolimus Enhances the Magnitude and Quality of Viral‐Specific CD8+ T‐Cell Responses to Vaccinia Virus Vaccination in Rhesus Macaques , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  P. Worley,et al.  The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.

[16]  P. Shrikant,et al.  Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines , 2011, British Journal of Cancer.

[17]  C. Parent,et al.  Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. , 2011, Blood.

[18]  D. Withers,et al.  Mammalian models of extended healthy lifespan , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[19]  T. Horvath,et al.  An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. , 2010, Immunity.

[20]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[21]  Mark J. Miller,et al.  Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. , 2010, Immunity.

[22]  H. Waldmann,et al.  mTOR signalling and metabolic regulation of T cell differentiation. , 2010, Current opinion in immunology.

[23]  B. Pulendran,et al.  A Versatile Role of Mammalian Target of Rapamycin in Human Dendritic Cell Function and Differentiation , 2010, The Journal of Immunology.

[24]  Greg M. Delgoffe,et al.  The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. , 2010, Immunity.

[25]  Hongbo Chi,et al.  S1P1-mTOR axis directs the reciprocal differentiation of TH1 and regulatory T cells , 2010, Nature Immunology.

[26]  A. Kirk,et al.  Cutting Edge: Rapamycin Augments Pathogen-Specific but Not Graft-Reactive CD8+ T Cell Responses , 2010, The Journal of Immunology.

[27]  D. Schatz,et al.  Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. , 2010, Molecular cell.

[28]  C. Spencer,et al.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. , 2010, Immunity.

[29]  P. Coffer,et al.  Human CD34-Derived Myeloid Dendritic Cell Development Requires Intact Phosphatidylinositol 3-Kinase–Protein Kinase B–Mammalian Target of Rapamycin Signaling , 2010, The Journal of Immunology.

[30]  C. Macedo,et al.  mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. , 2010, Blood.

[31]  T. Horvath,et al.  Regulatory T cells in obesity: the leptin connection. , 2010, Trends in Molecular Medicine.

[32]  O. Schwartz,et al.  Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. , 2010, Immunity.

[33]  R. Ahmed,et al.  The role of mTOR in memory CD8+ T‐cell differentiation , 2010, Immunological reviews.

[34]  S. Grinstein,et al.  In vivo requirement for Atg5 in antigen presentation by dendritic cells. , 2010, Immunity.

[35]  S. Crotty,et al.  Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation , 2010, Nature Immunology.

[36]  Qingsheng Li,et al.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. , 2010, Immunity.

[37]  David K. Finlay,et al.  Phosphoinositide 3‐kinase and the mammalian target of rapamycin pathways control T cell migration , 2010, Annals of the New York Academy of Sciences.

[38]  Loise M. Francisco,et al.  PD-L1 regulates the development, maintenance, and function of induced regulatory T cells , 2009, The Journal of experimental medicine.

[39]  Yang Liu,et al.  mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells , 2009, Science Signaling.

[40]  R. DePinho,et al.  PI3 Kinase Signals BCR-Dependent Mature B Cell Survival , 2009, Cell.

[41]  Janet M. Thornton,et al.  Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span , 2009, Science.

[42]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[43]  Russell G. Jones,et al.  Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.

[44]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[45]  R. Proia,et al.  S1P1 receptor overrides regulatory T cell-mediated immune suppression through Akt-mTOR , 2009, Nature Immunology.

[46]  D. Littman,et al.  Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.

[47]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[48]  R. Hunter,et al.  Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells , 2009, Nature Medicine.

[49]  K. Stuhlmeier,et al.  The TSC-mTOR signaling pathway regulates the innate inflammatory response. , 2008, Immunity.

[50]  B. Pulendran,et al.  Toll-like receptor–mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway , 2008, Nature Immunology.

[51]  S. Matsuda,et al.  Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. , 2008, Blood.

[52]  David K. Finlay,et al.  T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR , 2008, Proceedings of the National Academy of Sciences.

[53]  David K. Finlay,et al.  Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking , 2008, Nature Immunology.

[54]  A. Khoruts,et al.  De novo induction of antigen‐specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR , 2008, Journal of leukocyte biology.

[55]  C. Benoist,et al.  The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells , 2008, The Journal of experimental medicine.

[56]  Surojit Sarkar,et al.  Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates , 2008, The Journal of experimental medicine.

[57]  L. Guarente,et al.  Genetic links between diet and lifespan: shared mechanisms from yeast to humans , 2007, Nature Reviews Genetics.

[58]  E. Wherry,et al.  Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. , 2007, Immunity.

[59]  Nikhil S. Joshi,et al.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.

[60]  Zhiliang Wang,et al.  Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance1 , 2007, The Journal of Immunology.

[61]  M. Bevan,et al.  Effector and memory CTL differentiation. , 2007, Annual review of immunology.

[62]  C. Klebanoff,et al.  CD8+ T‐cell memory in tumor immunology and immunotherapy , 2006, Immunological reviews.

[63]  Thierry Boon,et al.  Human T cell responses against melanoma. , 2006, Annual review of immunology.

[64]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[65]  M. Battaglia,et al.  Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.

[66]  Hermann Wagner,et al.  Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[67]  E. Wherry,et al.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.

[68]  A. Thomson,et al.  Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. , 2003, Blood.

[69]  M. Hall,et al.  Activation of mTORC 2 by Association with the Ribosome , 2011 .